期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 139, 期 13, 页码 4769-4779出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.6b12800
关键词
-
资金
- EPSRC
- GlaxoSmithKline (GSK)
- GlaxoSmithKline
We report an investigation of the Chan Lam amination reaction. A combination of spectroscopy, computational modeling, and crystallography has identified the structures of key intermediates and allowed a complete mechanistic description to be presented, including off-cycle inhibitory processes, the source of amine and organoboron reactivity issues, and the origin of oxidation/protodeboronation side reactions. Identification of key mechanistic events has allowed the development of a simple solution to these issues: manipulating Cu(I) -> Cu(II) oxidation and exploiting three synergistic roles of boric acid has allowed the development-of a general catalytic Chan Lam amination, overcoming long-standing and unsolved amine and organoboron limitations of this valuable transformation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据